Tata Medical and Diagnostics Ltd. (Tata MD)- the healthcare venture from the Tata Group, India’s leading business conglomerate has reportedly acquired AccessBell- a San Francisco-based enterprise solutions startup for an undisclosed sum.
Established in March 2020 at the onset of coronavirus outbreak, AccessBell has been designed to offer teleconferencing services that help deliver healthcare solutions. This novel facility gained the attention of Tata Medical and Diagnostics, which was seeking different options to support its virtual health consultation services.
According to Martin Aguinis, Co-Founder and CEO of AccessBell, the company realized that video consultation was gaining traction, especially during the pandemic and yet the available video solutions did not integrate well with the prevailing systems.
Kamil Ali, Co-Founder and CTO, AccessBell added that the firm’s low-bandwidth, frictionless video technology focuses on offering high-quality patient care.
For the record, the American startup was a part of the Pear VC summer accelerator program and registered investment from Contour Ventures, University of Chicago, Decent Capital, and the MBA Fund.
Soon after its launch, AccessBell grew to a 6-figure ARR that offered video conferencing services and supported the best-in-class performance.
As per an official statement by Tata MD- the startup’s healthcare technology offering- AccessBell Telehealth complements Tata’s electronic health record systems, healthcare management software, and medical devices.
The company claims to be securing the real-time videos in their cloud system, supporting multiple uses for virtual case, including maternal-fetal medicine, rural ambulatory, pediatrics, and high-demand specialties like cardiology, psychology, and neurology.
Recently, Tata MD invested in online pharmacy and telemedicine solutions provider- 1mg, along with Curefit- a health and wellness startup.
Both these deals are apparently preparing the foundation for an acquisition in the future by Tata Digital- the digital services business of the Tata Group conglomerate.
In other news, Tata Medical and Diagnostics has also introduced ‘Tata MD CHECK’ which claims to be the first CRISPR Cas-9 based coronavirus test across the globe.